Showing results (11-20 of 17) with videos related to
Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
PLOS Global Public Health|January 8, 2024
Stigma, depression, quality of life, and the need for psychosocial support among people with tuberculosis in Indonesia: A multi-site cross-sectional studyAhmad Fuady, Bustanul Arifin, Ferdiana Yunita, et al.Infectious Diseases of Poverty|December 2, 2024
Community-based psychosocial support interventions to reduce stigma and improve mental health of people with infectious diseases: a scoping reviewMariska Anindhita, Matsna Haniifah, Arieska Malia Novia Putri, et al.Plos One|February 9, 2023
The development of the national tuberculosis research priority in Indonesia: A comprehensive mixed-method approachTrisasi Lestari, Ahmad Fuady, Finny Fitry Yani, et al.Pneumonia (Nathan Qld.)|January 4, 2019
Risk factors associated with nasopharyngeal carriage and density of <i>Streptococcus pneumoniae</i>, <i>Haemophilus influenzae</i>, <i>Moraxella catarrhalis</i>, and <i>Staphylococcus aureus</i> in young children living in IndonesiaEddy Fadlyana, Eileen M Dunne, Kusnandi Rusmil, et al.Plos One|April 13, 2018
Carriage of Streptococcus pneumoniae, Haemophilus influenzae, Moraxella catarrhalis, and Staphylococcus aureus in Indonesian children: A cross-sectional studyEileen M Dunne, Chrysanti Murad, Sunaryati Sudigdoadi, et al.Vaccine|April 4, 2024
Immunogenicity and safety of SARS-CoV-2 recombinant protein subunit vaccine (IndoVac) adjuvanted with alum and CpG 1018 in Indonesian adults: A phase 3, randomized, active-controlled, multicenter trialAsrawati Nurdin, Yetty Movieta Nency, Martira Maddeppungeng, et al.Human Vaccines & Immunotherapeutics|December 5, 2024
Safety and immunogenicity of a SARS-CoV-2 recombinant protein subunit vaccine adjuvanted with Alum + CpG 1018 in healthy Indonesian adults: A multicenter, randomized, comparative, observer-blind, placebo-controlled phase 2 studyMartira Maddeppungeng, Asrawati Nurdin, Yetty Movieta Nency, et al.Pageof 2